BREAST CANCER MALE

This adverse event was reported 510 times

These drugs are most commonly taken by patients reporting BREAST CANCER MALE:

# Drug Count
0 FINASTERIDE 42
1 BICALUTAMIDE 29
2 FUROSEMIDE 15
3 ETANERCEPT 12
4 ADALIMUMAB 11
5 TESTOSTERONE 11
6 GOSERELIN 10
7 VALSARTAN 9
8 ANASTROZOLE 8
9 ATORVASTATIN CALCIUM 8
See all common drugs associated with BREAST CANCER MALE

BREAST CANCER MALE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BICALUTAMIDE 29 0.0019
1 TESTOSTERONE ENANTHATE 3 0.0018
2 PINDOLOL 1 0.0012
3 AMILORIDE HYDROCHLORIDE 1 0.0012
4 FLUTAMIDE 1 0.0010
5 DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE 1 0.0010
6 GOSERELIN 10 0.0007
7 GINKGO BILOBA 1 0.0007
8 FINASTERIDE 42 0.0007
9 CEFACLOR 1 0.0006
See all drugs enriched for association with BREAST CANCER MALE

BREAST CANCER MALE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 4 0.0058
1 5-alpha Reductase Inhibitor [EPC] 48 0.0005
2 Androgen Receptor Inhibitor [EPC] 30 0.0004
3 Androgen [EPC] 11 0.0004
4 Human C1 Esterase Inhibitor [EPC] 1 0.0003
5 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
6 GLP-2 Analog [EPC] 2 0.0001
7 Provitamin D2 Compound [EPC] 4 0.0001
8 Interleukin-23 Antagonist [EPC] 12 0.0001
9 Aromatase Inhibitor [EPC] 13 0.0001
See all drug classes enriched for association with BREAST CANCER MALE